Form 4: Seres Therapeutics Executive Exercises Stock Options and Sells Shares to Cover Taxes
SEC Form 4 Filing
Teresa L. Young, EVP, Chief Commercial & Strategy Officer of Seres Therapeutics, exercised restricted stock units and sold a portion of the acquired shares to cover tax obligations.
Summary
- On May 15, 2024, Teresa L. Young, EVP, Chief Commercial & Strategy Officer of Seres Therapeutics, exercised restricted stock units representing 2,656 shares of common stock.
- Following the exercise, Ms. Young sold 703 shares of common stock at a weighted average price of $0.94 per share, with prices ranging from $0.94 to $0.943.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2023, solely to cover tax obligations related to the vesting of the restricted stock units.
- After these transactions, Ms. Young directly owns 17,658 shares of Seres Therapeutics common stock and 29,219 restricted stock units.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects routine executive stock transactions for tax purposes under a pre-existing plan.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of Rule 10b5-1 plans allows insiders to sell shares in a predetermined manner, avoiding concerns about trading on non-public information. This transaction is typical for executives managing their equity compensation and tax liabilities.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders, as it is a routine sale of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/05/2023 | Date of adoption of Rule 10b5-1 trading plan. |
| 02/15/2024 | 25% of the restricted stock units vested and settled. |
| 05/15/2024 | Date of transaction: exercise of restricted stock units and sale of shares. |
| 05/17/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.